Details for Patent: 11,833,151
Which drugs does patent 11,833,151 protect, and when does it expire?
Patent 11,833,151 protects LYTGOBI and is included in one NDA.
This patent has twenty-eight patent family members in twenty-one countries.
Summary for Patent: 11,833,151
| Title: | Pharmaceutical composition including sodium alkyl sulfate |
| Abstract: | The object of the present invention is to improve the dissolution and the absorption of (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl-1-pyrrolidinyl)-2-propen-1-one effective as an antitumor agent from a pharmaceutical formulation comprising the same. Provided is a pharmaceutical composition comprising (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl-1-pyrrolidinyl)-2-propen-1-one in combination with sodium alkyl sulfate having an alkyl group containing 10 to 18 carbon atoms, in particular, with sodium lauryl sulfate. |
| Inventor(s): | Kenji Kusumoto, Sadahiro Miyamura |
| Assignee: | Taiho Pharmaceutical Co Ltd |
| Application Number: | US16/982,377 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 11,833,151
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taiho Oncology | LYTGOBI | futibatinib | TABLET;ORAL | 214801-001 | Sep 30, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Taiho Oncology | LYTGOBI | futibatinib | TABLET;ORAL | 214801-002 | Jul 28, 2025 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,833,151
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019239404 | ⤷ Start Trial | |||
| Brazil | 112020018697 | ⤷ Start Trial | |||
| Canada | 3094431 | ⤷ Start Trial | |||
| China | 111867594 | ⤷ Start Trial | |||
| Denmark | 3769765 | ⤷ Start Trial | |||
| European Patent Office | 3769765 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
